willdate

16 POSTS 0 COMMENTS

Astura Medical receives 510(k) clearance for ALTA anterior cervical corpectomy spacer...

Astura Medical has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Alta anterior cervical corpectomy spacer system. Available in either...

Comorbidities and surgical complication linked to increased readmission after revision lumbar...

Relevant patient comorbidities and surgical complications are associated with increased readmission within 90 days of elective revision lumbar fusion surgery, a retrospective study published...

Novartis announces results of PREVENT study

Novartis today announced detailed results from the randomised, double-blind, placebo-controlled phase III PREVENT study, evaluating the efficacy and safety of Cosentyx (secukinumab) in patients...

Tim Pigott

A consultant neurosurgeon and the current president of EUROSPINE, Tim Pigott talks to Spinal News International about his career so far. Outside of his...

Outcomes of SCOUT interbody fusion trial detailed

Spineology has announced that 24-month outcomes data from SCOUT clinical trial were presented by John Chi (Brigham and Women’s Hospital, Boston, USA), at the...

Nevro receives US FDA approval for Senza Omnia spinal cord stimulation...

  Nevro has received approval from the US Food and Drug Administration (FDA) for the Senza Omnia spinal cord stimulation system to treat chronic pain....

Astura Medical announces Texas relocation

Astura
Spine technology company Astura Medical has announced the relocation of its corporate headquarters from Carlsbad, California to Irving, Texas. The move was effective November...

AI-based classification may guide preoperative decisions in ASD patients

Hierarchical clustering of patient data using artificial intelligence (AI) can identify patterns that may guide preoperative decision-making in adult spinal deformity (ASD) surgery by...

Stryker receives FDA 510(k) clearance for Sahara Lateral 3D interbody system

Stryker Sahara
Stryker has received 510(k) clearance from the US Food and Drug Administration (FDA) for the Sahara Lateral 3D expandable interbody system. The product will...

Laboratory markers could predict outcomes for spinal metastases patients

Spinal metastases patients with low serum albumin and elevated platelet-lymphocyte ratio (PLR) should be advised regarding the impact of these laboratory markers on outcomes,...

Behavioural intervention increases physical activity in lumbar surgery patients

A psychosocial behavioural intervention administered in the spine care setting was successful in increasing physical activity after recuperation from lumbar surgery, a trial has...

IDCT clinical study passes final safety review

DiscGenics has announced that it has received the go-ahead from an independent data safety monitoring committee (DSMC) to enrol the final 24 patients in...

GTX Medical and NeuroRecovery Technologies announce merger

GTX Medical (formerly G-Therapeutics) and NeuroRecovery Technologies (NRT) have announced a merger to further the development of neuromodulation therapies to aid functional recovery of...

Stryker completes acquisition of Mobius Imaging

Stryker
Stryker has completed the acquisition of Mobius Imaging and its sister company, GYS Tech, which trades as Cardan Robotics. The acquisition was agreed in September...

EUROSPINE 2019: Decompressive surgery remains the ‘gold-standard’ for lumbar spinal stenosis...

Long-term results demonstrate that even though implantation of a stand-alone interspinous process device (IPD) can be successful in treating intermittent neurogenic claudication (INC), the...

Synaptive offers Modus V surgical microscope to spine market

Synaptive Medical will offer its robotic surgical microscope, Modus V, to the spine market as part of an expanded marketing agreement with Stryker. The...